Fresh Rounds

Beacon Biosignals, Inc. funding

Beacon Biosignals, Inc., a technology company based in Boston, MA, filed a Form D with the SEC on April 15, 2026 and reported $103M raised.

Amount raised$103M
Offering size$103M
Filed with the SECApril 15, 2026
First saleOctober 7, 2025
IndustryOther Technology
SecuritiesEquity
LocationBoston, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far43
Minimum investment—
Revenue rangeDecline to Disclose

Other technology rounds in Massachusetts